This page lists the SEC filings reported by Patel Tushar Bhikhubhai.
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2024-05-13 | Patel Tushar Bhikhubhai | Amneal Pharmaceuticals, Inc. | 53,578,209 | 17.4% | EDGAR |
SC 13D/A | 2023-11-08 | Patel Tushar Bhikhubhai | Amneal Pharmaceuticals, Inc. | 53,578,209 | 17.5% | EDGAR |
SC 13D/A | 2023-10-18 | Patel Tushar Bhikhubhai | Amneal Pharmaceuticals, Inc. | 53,578,209 | 25.8% | EDGAR |
SC 13D/A | 2019-08-26 | Patel Tushar Bhikhubhai | Amneal Pharmaceuticals, Inc. | - | 29.5% | EDGAR |
SC 13D | 2018-07-09 | Patel Tushar Bhikhubhai | Amneal Pharmaceuticals, Inc. | 53,578,209 | 31.8% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.